Antitumor activity of a fusion of esophageal carcinoma cells with dendritic cells derived from cord blood

Vaccine

Volumn 23, Issue 45, 2005, Pages 5225-5230

  Guo, Guanghua ^a   Suzuan, Chen ^a   Juan, Zhang ^a   Lili, Luo ^a   Jing, Yu ^a   Hongmei, Dong ^a   Hong, Xu ^a   Zhongjing, Su ^a   Libiao, Wu ^a  

^a SHANTOU UNIVERSITY MEDICAL COLLEGE   (China)

Author keywords

Cancer vaccine; Cell fusion; Dendritic cell; Esophageal carcinoma cell line

Indexed keywords

CANCER VACCINE; CD34 ANTIGEN; DENDRITIC CELL VACCINE; HLA DR ANTIGEN; MACROGOL DERIVATIVE; RECOMBINANT GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; RECOMBINANT STEM CELL FACTOR; RECOMBINANT TUMOR NECROSIS FACTOR ALPHA;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL; CELL CULTURE; CELL ISOLATION; CELL PROLIFERATION; CELL SELECTION; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; ESOPHAGUS CARCINOMA; FLOW CYTOMETRY; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; IMMUNOSTIMULATION; INCUBATION TIME; LYMPHOCYTE PROLIFERATION; PHENOTYPE; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; TUMOR IMMUNITY; UMBILICAL CORD BLOOD;

ANIMALS; ANTIGENS, CD34; CANCER VACCINES; CELL FUSION; CELL PROLIFERATION; DENDRITIC CELLS; ESOPHAGEAL NEOPLASMS; FETAL BLOOD; FLOW CYTOMETRY; HEMATOPOIETIC STEM CELLS; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHOCYTE CULTURE TEST, MIXED; MICE; T-LYMPHOCYTES; T-LYMPHOCYTES, CYTOTOXIC;

EID: 26644444784     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2005.07.080     Document Type: Article

References (22)

1. E.S. Trombetta, M. Ebersold, W. Garrett, M. Pypaert, and I. Mellman Activation of lysosomal function during dendritic cell maturation Science 299 2003 1400 1403
2. X. Cao, W. Zhang, J. Wang, M. Zhang, X. Huang, and H. Hamada Therapy of established tumor with a hybrid cellular vaccine generated by using granulocyte-macrophage colony-stimulating factor genetically modified dendritic cells Immunology 97 1999 616 625
3. J. Gong, N. Nikrui, D. Chen, S. Koido, Z. Wu, and Y. Tanaka Fusions of human ovarian carcinoma cells with autologous or allogeneic dendritic cells induce antitumor immunity J Immunology 165 2000 1705 1711
4. L. Zitvogel, J.I. Mayordomo, T. Tjandrawan, A.B. DeLeo, M.R. Clarke, and M.T. Lotze Therapy of murine tumors with tumor peptide-pulsed dendritic cells: dependence on T cells, B7 costimulation, and T helper cell 1- associated cytokines J Exp Med 183 1 1996 87
5. Y. Wan, J. Bramson, R. Carter, F. Graham, and J. Gauldie Dendritic cells transduced with an adenoviral vector encoding a model tumor-associated antigen for tumor vaccination Human Gene Ther 8 11 1997 1355 1363
6. P. DeMatos, Z. Abdel-Wahab, C. Vervaert, and H.F. Seigler Vaccination with dendritic cells inhibits the growth of hepatic metastases in B6 mice Cell Immunol 185 1 1998 65 74
7. U. Grohmann, R. Bianchi, E. Ayroldi, ML. Belladonna, D. Surace, and MC. Fioretti A tumor-associated and self antigen peptide presented by dendritic cells may induce T cell anergy in vivo, but IL-12 can prevent or revert the anergic state J Immunol 158 1997 3593 3602
8. M. Wu, W. Gunning, and M. Ratnam Expression of folate receptor type alpha in relation to cell type, malignancy, and differentiation in ovary, uterus, and cervix Cancer Epidemiol Biomarkers Prev 8 1999 775 782
9. J. Gong, D. Avigan, D. Chen, Z. Wu, S. Koido, and M. Kashiwaba Activation of antitumor cytotoxic T lymphocytes by fusions of human dendritic cells and breast carcinoma cells Proc Natl Acad Sci USA 97 2000 2715 2718
10. R.M. Steinman The dendritic cell system and its role in immunogenicity Annu Rev Immunol 9 1991 271 296
11. K.A. Berlyn, B. Schultes, B. Leveugle, A.A. Noujaim, R.B. Alexander, and D.L. Mann Generation of CD4 and CD8 T lymphocyte responses by dendritic cells armed with PSA/anti-PSA (antigen/antibody) complexes Clinical Immunology 101 2001 276 283
12. E.S. Trombetta, M. Ebersold, W. Garrett, M. Pypaert, and I. Mellman Activation of lysosomal function during dendritic cell maturation Science 299 2003 1400 1403
13. N. Mach, S. Silke Gillessen, B. Wilson, C. Sheehan, M. Mihm, and G. Dranoff Differences in dendritic cells stimulated in vivo by tumors engineered to secrete granulocyte-macrophage colony-stimulating factor or Flt3-ligand Cancer Res 60 2000 3239 3246
14. T.L. Whiteside, A. Gambotto, A. Albers, J. Stanson, and E.P. Cohen Human tumor-derived genomic DNA transduced into a recipient cell induces tumor-specific immune responses ex vivo Proc Natl Acad Sci USA 99 2002 9415 9420
15. J. Banchereau, B. Schuler-Thurner, A.K. Palucka, and G. Schuler Dendritic cells as vectors for therapy Cell 106 2001 271 274
16. S.R. Riddell Progress in cancer vaccines by enhanced self-presentation Proc Natl Acad Sci USA 98 2001 8933 8935
17. A. Heiser, D. Coleman, J. Dannull, D. Yancey, M.A. Maurice, and C.D. Lallas Autologous dendritic cells transfected with prostate-specific antigen RNA stimulate CTL responses against metastatic prostate tumors J Clin Inves 109 2002 409 417
18. M. Bellone, D. Cantarella, P. Castiglioni, M.C. Crosti, A. Ronchetti, and M. Moro Relevance of the tumor antigen in the validation of three vaccination strategies for melanoma J Immunol 165 2000 2651 2656
19. V. Rocha, J. Cornish, E.L. Sievers, A. Filipovich, F. Locatelli, and C. Peters Comparison of outcomes of unrelated bone marrow and umbilical cord blood transplants in children with acute leukemia Blood 97 2001 2962 2971
20. P.G. Beatty, K.M. Boucher, M. Mori, and E.L. Milford Probability of finding HLA-mismatched related or unrelated marrow or cord blood donors Hum Immunol 61 2000 834 840
21. L.I. Yan, L.I.A.O. Can, T.A.N.G. Xuewei, X.I.E. Xingmei, H.U.A.N.G. Yining, and W.U. Jieying Analysis of HLA Matching Probability in Guangzhou Cord Blood Bank J Exp Hematol 11 4 2003 424 428
22. + cell-derived NK cell cytotoxicity by dendritic cells J Immunol 166 2001 1590 1600